Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06004232 · ClinicalTrials.gov registry record · NA

Prenatal Yoga to Prevent Postpartum Depression

A NA study of Postpartum Depression, sponsored by Henry Ford Health System.

Active
Registry status
NA
Development phase
62
Enrollment target
1
Study location

NCT06004232: Active NA study of Postpartum Depression, sponsored by Henry Ford Health System.

NCT06004232 is a NA study of Postpartum Depression that is active but no longer recruiting, run by Henry Ford Health System. The registered enrollment target is 62 participants, below the 474-participant average among 47 other Postpartum Depression trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06004232, a NA study of Postpartum Depression, is active but no longer recruiting, sponsored by Henry Ford Health System.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
62 participants
Enrollment target
1
Study location

Study Summary

Although psychological interventions exist for the prevention of PPD, a yoga-based intervention to prevent PPD among at-risk women utilizes a similar theoretical foundation (i.e., mindfulness), may be more acceptable to women of minority status, and may confer additional physical activity benefits. The purpose of this pilot study is to determine the effectiveness of using a virtually delivered prenatal yoga intervention for the prevention of PPD among at-risk women in a diverse health care system and explore preliminary factors which influence implementation of the intervention. This study has 2 phases: Phase 1 will evaluate facilitators and barriers to intervention implementation among patient, clinician, and health system stakeholders, followed by an open trial, and Phase 2 will include conducting an 8-session pilot randomized controlled trial to assess the feasibility and acceptability of the proposed prenatal yoga intervention among women with a history of depression, as well as the onset and course of PPD and mediating factors. The specific aims are to: 1) Optimize delivery of a yoga intervention within a healthcare system to prevent PPD through examining facilitators and barriers of implementation, 2) Examine feasibility, acceptability and satisfaction of the intervention within a health care system, and 3) Evaluate preliminary effectiveness of the intervention on PPD and proposed mechanisms. For Phase 1, separate focus groups with patient stakeholders and clinician and administrative stakeholders will inform intervention implementation, and an open trial to refine and optimize the intervention. For Phase 2, women with a history of depression who are 8-28 weeks pregnant will be randomized to the intervention group (n=24) or treatment-as-usual (n=24) and will complete survey measures at baseline, post-intervention, and 1 and 3 months postpartum. It is hypothesized that the intervention will be feasible and acceptable, engage women of racial/ethnic minority stat

Primary Outcome

The Edinburgh Postnatal Depression Scale (EPDS) will be used to measure presence of postpartum depression (yes/no). EPDS scores range from 0 to 30; a score of 10 or above indicates the presence of current depression symptoms.

Conditions Studied

Interventions

  • BEHAVIORAL Treatment as Usual (TAU)
  • BEHAVIORAL Prenatal Yoga to Prevent Postpartum Depression (PRY-D) intervention

Study Locations (1)

Michigan

  • Henry Ford Health - Detroit

Trial Details

FieldValue
Enrollment Target 62 participants
Start Date 2025-02-26
Est. Completion 2026-03
Phase NA
Henry Ford Health System

234 total trials

What the registry record for NCT06004232 still lists

NCT06004232 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 62 participants, a relatively small participant target, below the 474-participant average among 47 other Postpartum Depression trials with a reported enrollment target (87% lower).

The record links to 1 condition, with Postpartum Depression appearing as the primary indexed condition, and to 2 interventions - of which Treatment as Usual (TAU) is the first listed.

NCT06004232 reports a single indexed study location in Michigan.

Frequently Asked Questions

What is clinical trial NCT06004232 about?

NCT06004232 is a clinical study titled "Prenatal Yoga to Prevent Postpartum Depression". Although psychological interventions exist for the prevention of PPD, a yoga-based intervention to prevent PPD among at-risk women utilizes a similar theoretical foundation (i.e., mindfulness), may be more acceptable to women of minority status, and may confer additional physical activity benefits. ...

What is the current status of trial NCT06004232?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 62 participants. The study started on 2025-02-26. Estimated completion is 2026-03.

What conditions does trial NCT06004232 study?

This clinical trial studies the following conditions: Postpartum Depression.

What interventions are being tested in trial NCT06004232?

The interventions under investigation include: Treatment as Usual (TAU) (BEHAVIORAL), Prenatal Yoga to Prevent Postpartum Depression (PRY-D) intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT06004232?

This trial is sponsored by Henry Ford Health System, which has 234 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06004232 being conducted?

This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Postpartum Depression

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06004232's enrollment target sits among peer trials

62 34th of 47 higher than 14 of 47 other Postpartum Depression trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Postpartum Depression trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03231150 · 62 participants · NA

    Plantar Fasciitis Randomized Clinical Control Trial

  • NCT03458676 · 62 participants · NA

    Radiologic Pathologic Correlation of Advanced MR Imaging to Guide the Biopsy of Cerebral Malignancies

  • NCT03596086 · 62 participants · Phase 1

    HSV-tk + Valacyclovir + SBRT + Chemotherapy for Recurrent GBM

  • NCT03603405 · 62 participants · Phase 1

    HSV-tk and XRT and Chemotherapy for Newly Diagnosed GBM

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06004232, the US trial registry maintained by the National Library of Medicine. NCT06004232 (small enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.